Wong Stephanie
Insider CIK 1555744 · CALA VP, FINANCE AND SECRETARY · ANTX Director · SCLN VP, Finance and Controller
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 10,362 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 24,999 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 24,999 | — | $0 | 24,999 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 20,400 | — | $0 | 20,400 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 19,111 | — | $0 | 19,111 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-06-19 | 2024-06-21 | 64,503 | — | $0 | 64,503 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 23,742 | — | $0 | 23,742 | SEC↗ |
| CALA Calithera Biosciences, Inc | F Tax w/h | 2023-01-23 | 2023-01-25 | 317 | $0.45 | $143 | 6,287 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 10,362 | — | $0 | 10,362 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2022-01-25 | 2022-01-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | F Tax w/h | 2022-01-21 | 2022-01-25 | 5,586 | $0.49 | $2.7K | 132,085 | SEC↗ |
| CALA Calithera Biosciences, Inc | F Tax w/h | 2022-01-04 | 2022-01-06 | 18,077 | $0.66 | $11.9K | 137,671 | SEC↗ |
| CALA Calithera Biosciences, Inc | F Tax w/h | 2021-11-08 | 2021-11-09 | 15,566 | $0.87 | $13.5K | 155,748 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award | 2021-11-05 | 2021-11-09 | 30,000 | — | $0 | 171,314 | SEC↗ |
| CALA Calithera Biosciences, Inc | F Tax w/h | 2021-10-28 | 2021-10-29 | 45,965 | $1.89 | $86.9K | 141,314 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award | 2021-10-27 | 2021-10-29 | 90,000 | — | $0 | 187,279 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2021-01-20 | 2021-01-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 103,156 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award | 2021-01-20 | 2021-01-22 | 35,000 | — | $0 | 73,156 | SEC↗ |
| CALA Calithera Biosciences, Inc | S Sale | 2020-04-15 | 2020-04-17 | 5,000 | $8.00 | $40.0K | 30,082 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2020-01-17 | 2020-01-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | M Exercise deriv | 2019-06-19 | 2019-06-21 | 10,000 | — | $0 | 13,284 | SEC↗ |
| CALA Calithera Biosciences, Inc | M Exercise | 2019-06-19 | 2019-06-21 | 10,000 | $2.64 | $26.4K | 31,751 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2019-01-10 | 2019-01-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | M Exercise deriv | 2018-02-23 | 2018-02-27 | 10,000 | — | $0 | 21,596 | SEC↗ |
| CALA Calithera Biosciences, Inc | M Exercise | 2018-02-23 | 2018-02-27 | 10,000 | $2.64 | $26.4K | 15,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2018-01-11 | 2018-01-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | S Sale | 2017-07-17 | 2017-07-19 | 3,552 | $18.41 | $65.4K | 10,550 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-04-04 | 2013-04-08 | 50,000 | — | $0 | 50,000 | SEC↗ |